LY2157299
Important Notice: For research use only. We do not sell to patients.
Not your Region? View all Distributors
Important Notice: For research use only. We do not sell to patients.
Not your Region? View all Distributors
Discription | LY2157299 is an orally active transforming growth factor beta receptor (TGF-βR) kinase inhibitor. | ||
---|---|---|---|
Targets |
|
Catalog Num | A11017 |
---|---|
Formula | C22H19N5O |
Molecular Weight | 369.4 |
CAS Number | 700874-72-2 |
SMILES | CC1=CC=CC(=N1)C2=NN3CCCC3=C2C4=C5C=C(C=CC5=NC=C4)C(=O)N |
Synonyms | LY-2157299 |
Storage | Store lyophilized at -20ºC, keep desiccated. |
In vitro (25°C) | DMSO | 66 mg/mL (178.65 mM) | |
Water | Insoluble | ||
Ethanol | Insoluble | ||
In vivo | 1%CMC-Na | 28 mg/mL | |
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 27.07 mL | 135.35 mL | 270.71 mL |
0.5 mM | 5.41 mL | 27.07 mL | 54.14 mL |
1 mM | 2.71 mL | 13.54 mL | 27.07 mL |
5 mM | 0.54 mL | 2.71 mL | 5.41 mL |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2